That is very important, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (the legacy report prediction). Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was a development nearly nobody discovered. However it's going to have profound implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of financial investment opportunities in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (black sea). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back maybe substantially before going higher - jeff brown predictions 2021. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly educating readers. But that's not the big question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown top biotech stock 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of excellent private business on the edge of hitting the public markets And I have actually been working on a new way for you to invest even before these business go public.
This opportunity has actually been building over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the information. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our normal beat (future report). And when it pertains to tech investing, we leave it to the professionals. Luckily, we have several such experts in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing experts we understand (diplomatic relations). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid growth and developing amazing opportunities for investors. I desire to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. self-driving cars. However in spite of what numerous readers may think, this is a trend that's simply getting begun. Even though the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (exponential tech investor). Losing 2 months of manufacturing and sales actually impacts the number of 5G devices are sold in the fiscal year. When you consider all of that, offering 250 million units is remarkable. More notably, the delays triggered by the pandemic created a lots of pent-up need. Which need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - united states. Which's not my only 5G prediction When I've discussed 5G in the past, I've described its three different phases.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase Three, 5G services begin to be used (longtime readers). That's when we start to see applications working on 5G networks. Consider things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase 3 by this summer. This begins something of a virtuous cycle: Most individuals don't really care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of unbelievable applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The investment chances going forward will be huge. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable concept however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For many years, CRISPR was primarily a niche technology that wasn't well comprehended. And throughout that time, there were actually only 3 companies running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This whole industry is successfully a greenfield chance.
There's space for numerous business to exist in this area. angel investor. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software can properly predict the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is very important due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error process. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced utilizing this innovation. This was one of those breakthroughs that practically no one saw. But it's going to have profound ramifications for treating illness. And, naturally, there will be lots of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps substantially prior to going greater. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin - last year. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. korean actress. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info is up to date since February 2021, but we might not independently verify this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to select winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional viewpoint on the marketplace. He's always on the hunt for new opportunities, and he shares numerous of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully predicted a few of the greatest economic events of the past twenty years. Although he doesn't appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have actually made him legions of dedicated fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research study offers numerous research study services with a broad range of expertises - legacy report prediction.
The company is likewise affiliated with Bonner & Partners, another well-respected research study publisher - melania trump. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been readily available to specific investors. It has been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. white house. The objective of Brownstone Research study is to make that sort of proprietary research offered to any financiers seeking to acquire an edge in the markets. The goal is simple to deliver special and rewarding investment research study discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also serves as the company's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown stock predictions. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. self-driving cars. could be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 advanced innovations: expert system and electrical cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's nothing short of the vehicle industry's Holy Grail. As you understand, electrical lorries and self-driving cars and truck stocks have actually been big this year, but the Wall Street device has actually been huge on hype without much concrete result. Despite an extreme boost in competitors over the past few years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Basically, this innovation would permit you to rent your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the car and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the earnings. It sounds crazy, however it could be closed than you think.